Skip to main content
TipRanks
Go Ultimate75% OFF
Caldera Therapeutics Inc logo

Caldera Therapeutics Inc: Valuation, Funding & Investors

https://www.calderatx.com/Therapeutics

Caldera Therapeutics is a clinical-stage biotechnology company developing first-in-class bispecific antibody therapeutics for inflammatory bowel disease (IBD) and other immunologic and inflammatory diseases. The company’s lead program, CLD-423, targets the IL-23p19 and TL1A pathways and was in-licensed for global development and commercialization from Qyuns Therapeutics Co., Ltd.

Leadership & Board

Current Number of Employees
18
Current LinkedIn Followers
2,021

Latest Estimated Valuation

Total Amount Raised
$38M
Total Funding Rounds
1
Latest Funding Amount
$38M
Latest Funding Round
Series A

Employee Trend

Caldera Therapeutics Inc had 18 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.

18Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Social Trend

Caldera Therapeutics Inc had 2,021 followers as of November 16, 2026. The number of followers increased by 39 (1.97%) week-over-week.

2,021Latest Followers Count
39(1.97%)Week-Over-Week Change
01,0002,0003,0004,000Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026Oct 26, 2026Nov 09, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 14, 2026Series A$37.50M―

Investors

Investor NameFunding Round
Omega FundsSeries A
Janus Henderson InvestorsSeries A
Wellington ManagementSeries A

Similar Companies

A snapshot of private companies similar to Caldera Therapeutics Inc, helping you discover and navigate related company profiles.

Related News and Analysis